People · Operator
Named in public records as an officer, director or promoter · active 2009–2019 · Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ardelyx, Inc. | — | Pharmaceuticals | Series D+ | $210.4M | $3.9B | 2016 |
| Zoo Entertainment, Inc | — | Other | Series B | $21.2M | $27.8M | 2009 |
| Fairway Tulsa Management Group, LLC | — | Other | Seed | $1.5M | $27.9M | 2019 |
David Rosenbaum at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Rosenbaum on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Smith | 1 | 42 |
| David Mott | 1 | 9 |
| Annalisa Jenkins | 1 | 8 |
| David Collier | 1 | 8 |
| Gordon Ringold | 1 | 7 |
| Richard Rodgers | 1 | 4 |
| Jay Wolf | 1 | 4 |
| Barry Regenstein | 1 | 4 |
| Jeremy Caldwell | 1 | 4 |
| Peter G. Schultz | 1 | 3 |
| Jeff Jacobs | 1 | 2 |
| Alex Krys | 1 | 2 |
| Robert Bazemore | 1 | 2 |
| Paul Korner | 1 | 2 |
| Richard G. Rodgers | 1 | 1 |
| Gordon G. Ringold | 1 | 1 |
| David G. Rosenbaum | 1 | 1 |
| Jeremy G. Caldwell | 1 | 1 |
| DAVID ROYSTER | 1 | 1 |
| Evan Gsell | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.